Apple, Ulta Beauty, AstraZeneca And A Real Estate Stock On CNBC's 'Final Trades' - Apple (NASDAQ:AAPL), AstraZeneca (NYSE:AZN)

On CNBC's “Halftime Report Final Trades,” Joshua Brown, co-founder and CEO of Ritholtz Wealth Management, said he remains long on Apple Inc. (NASDAQ:AAPL) .Supporting his view, Wedbush analyst Dan Ives, on Tuesday, reiterated Apple with an Outperform rating and maintained a $350 price target.Jim Lebenthal, partner at Cerity Partners, said AstraZeneca PLC (NYSE:AZN) is a high-quality pharmaceutical stock.On the earnings front, AstraZeneca, on Feb. 10, reported fourth-quarter 2025 sales of $15.50 billion, up ...